Key Features

Simple

Versatile

Proven

Product information

For a Cohesive and Stable Clot

High-performance Hemostasis is simpler than ever, with the only hemostatic agent indicated for minimal, mild, and moderate bleeding.  HEMOBLAST Bellows is designed to simplify and effectively meet your bleeding challenges as a proven, ready-to-use product with a versatile application.

HEMOBLAST Bellows is the only combination powdered surgical hemostat that contains thrombin, collagen, and chondroitin sulfate with demonstrated efficacy on minimal, mild, and moderate bleeding.

Physiological Hemostasis – HEMOBLAST Bellows contains (human-derived) thrombin. Thrombin converts fibrinogen to fibrin, a basic element in a blood clot.
Mechanical HemostasisThe (porcine-derived) collagen in HEMOBLAST Bellows supports a controlled swell. Additionally, in the coagulation cascade, collagen is known to induce platelet aggregation and coagulation.
Cohesion HEMOBLAST Bellows is the only hemostat that contains (bovine-derived) chondroitin sulfate, included for the purpose of providing cohesion between the wound and surrounding tissue.

Company profile

Dilon Technologies Inc.

Dolin Technologies Inc. is a women’s healthcare company that has expanded into biosurgery which develops, manufactures, and promotes innovative medical devices to healthcare providers.